Benign prostatic hyperplasia (BPH)

Intensive care medicine

Tamsulosin

Urology

Medical therapy

5 Alpha-Reductase Inhibitor

Hyperplasia

Internal medicine

Prostate

Gynecology

Medical treatment

Medicine

Finasteride

Lower urinary tract symptoms

Cancer

Urologic Clinics of North America

In this article, we review the primary medical treatments of BPH-associated male LUTS, with a focus on physiology, indications, and side effects. We cover selective alpha-1 antagonists, anticholinergics, PDE5 inhibitors, 5-alpha reductase inhibitors, and beta-3 agonists. Through a review of the literature, we provide our clinical pathway for the medical management of BPH, generally starting with tamsulosin in most men and progressing to combination therapy based on patient's response and symptoms.

Medical Treatment of Benign Prostatic Hyperplasia